← Leaderboards
Roger A Johns
Johns Hopkins University
$24,853,899
Attributed
$25,905,474
Total exposure
10
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$25,905,474 · 10
By mechanism
R01$14,669,029 · 6
UH3$4,873,818 · 1
P50$3,223,352 · 2
UH2$3,139,275 · 1
Top collaborators
- Qing Lin3 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Yuan-Xiang Tao$12,887,850
- Jennifer E Van Eyk$35,842,385
- Richard L Huganir$46,606,892
- David J. Linden$17,490,169
- Richard E Mains$9,772,587
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsMediatingIn VivoMolecularIn VitroPreventPulmonary HypertensionAnestheticsPlayNitric OxideInflammatorySclerodermaLungResponseFunctional DisorderCellsHypoxiaVascular RemodelingSignal TransductionProtein Protein InteractionComplexProtein FamilyNeuronsProduction
Grant awards (50)
Resistin regulates NLRP3 inflammasome in pulmonary hypertension$712,864
R01 · FY2025 · HL · contact PI
Resistin regulates NLRP3 inflammasome in pulmonary hypertension$688,819
R01 · FY2024 · HL · contact PI
Resistin regulates NLRP3 inflammasome in pulmonary hypertension$701,467
R01 · FY2023 · HL · contact PI
Mechanistic Actions of PDZ Domain Mediated Protein Interactions on Neural Development and Anesthetic-Mediated Neurotoxicity$458,510
R01 · FY2023 · GM · contact PI
Mechanistic Actions of PDZ Domain Mediated Protein Interactions on Neural Development and Anesthetic-Mediated Neurotoxicity$458,510
R01 · FY2022 · GM · contact PI
Mechanistic Actions of PDZ Domain Mediated Protein Interactions on Neural Development and Anesthetic-Mediated Neurotoxicity$465,527
R01 · FY2021 · GM · contact PI
DAMP Signaling Mediates HIMF-induced Pulmonary Hypertension$454,909
R01 · FY2021 · HL · contact PI
Mechanistic Actions of PDZ Domain Mediated Protein Interactions on Neural Development and Anesthetic-Mediated Neurotoxicity$5,011
R01 · FY2021 · GM · contact PI
Mechanistic Actions of PDZ Domain Mediated Protein Interactions on Neural Development and Anesthetic-Mediated Neurotoxicity$458,510
R01 · FY2020 · GM · contact PI
DAMP Signaling Mediates HIMF-induced Pulmonary Hypertension$454,909
R01 · FY2020 · HL · contact PI
DAMP Signaling Mediates HIMF-induced Pulmonary Hypertension$454,909
R01 · FY2019 · HL · contact PI
Targeting resitin and RELM-beta to treat pulmonary hypertension$1,627,841
UH3 · FY2018 · HL · contact PI
DAMP Signaling Mediates HIMF-induced Pulmonary Hypertension$454,909
R01 · FY2018 · HL · contact PI
Targeting resitin and RELM-beta to treat pulmonary hypertension$1,625,427
UH3 · FY2017 · HL · contact PI
Targeting PDZ to unravel early anesthetic exposure-produced cognitive dysfunction$425,261
R01 · FY2017 · GM · contact PI
Targeting resitin and RELM-beta to treat pulmonary hypertension$1,620,550
UH3 · FY2016 · HL · contact PI
Targeting PDZ to unravel early anesthetic exposure-produced cognitive dysfunction$382,139
R01 · FY2016 · GM · contact PI
Targeting PDZ to unravel early anesthetic exposure-produced cognitive dysfunction$60,334
R01 · FY2016 · GM · contact PI
Targeting resitin and RELM-beta to treat pulmonary hypertension$1,576,472
UH2 · FY2015 · HL · contact PI
Targeting PDZ to unravel early anesthetic exposure-produced cognitive dysfunction$382,139
R01 · FY2015 · GM · contact PI
Targeting resitin and RELM-beta to treat pulmonary hypertension$1,562,803
UH2 · FY2014 · HL · contact PI
Targeting PDZ to unravel early anesthetic exposure-produced cognitive dysfunction$382,135
R01 · FY2014 · GM · contact PI
Targeting resitin and RELM-beta to treat pulmonary hypertension$490,962
P50 · FY2012 · HL · contact PI
Targeting resitin and RELM-beta to treat pulmonary hypertension$491,841
P50 · FY2011 · HL · contact PI
HIMF/FIZZ1 IN PULMONARY HYPERTENSION/RIGHT HEART FAILURE$443,241
P50 · FY2011 · HL · contact PI
HIMF/FIZZ1 IN PULMONARY HYPERTENSION/RIGHT HEART FAILURE$446,446
P50 · FY2010 · HL · contact PI
HIMF/FIZZ1 IN PULMONARY HYPERTENSION/RIGHT HEART FAILURE$449,301
P50 · FY2009 · HL · contact PI
Interaction of Anesthetics with Neuronal PDZ Domains$346,953
R01 · FY2009 · GM · contact PI
Interaction of Anesthetics with Neuronal PDZ Domains$113,259
R01 · FY2009 · GM · contact PI
HIMF/FIZZ1 IN PULMONARY HYPERTENSION/RIGHT HEART FAILURE$438,914
P50 · FY2008 · HL · contact PI
Interaction of Anesthetics with Neuronal PDZ Domains$338,607
R01 · FY2008 · GM · contact PI
HIMF/FIZZ1 IN PULMONARY HYPERTENSION/RIGHT HEART FAILURE$462,647
P50 · FY2007 · HL · contact PI
Role of Spinal Cord PSD-93/Chapsyn-110 in Chronic Pain$368,191
R01 · FY2007 · NS · contact PI
Interaction of Anesthetics with Neuronal PDZ Domains$338,625
R01 · FY2007 · GM · contact PI
Interaction of Anesthetics with Neuronal PDZ Domains$423,704
R01 · FY2006 · GM · contact PI
Regulation of NO Signaling in Pulmonary Vaculature$399,144
R01 · FY2006 · HL · contact PI
Role of Spinal Cord PSD-93/Chapsyn-110 in Chronic Pain$379,187
R01 · FY2006 · NS · contact PI
Regulation of NO Signaling in Pulmonary Vaculature$408,750
R01 · FY2005 · HL
Role of Spinal Cord PSD-93/Chapsyn-110 in Chronic Pain$388,313
R01 · FY2005 · NS
Regulation of NO Signaling in Pulmonary Vaculature$408,750
R01 · FY2004 · HL
Role of Spinal Cord PSD-93/Chapsyn-110 in Chronic Pain$388,313
R01 · FY2004 · NS
NO SIGNALING IN MECHANISMS OF ANALGESIA AND ANESTHESIA$109,001
R01 · FY2004 · GM
Regulation of NO Signaling in Pulmonary Vasculature$408,750
R01 · FY2003 · HL
Role of Spinal Cord PSD-93/Chapsyn-110 in Chronic Pain$388,313
R01 · FY2003 · NS
NO SIGNALING IN MECHANISMS OF ANALGESIA AND ANESTHESIA$327,000
R01 · FY2003 · GM
NO SIGNALING IN MECHANISMS OF ANALGESIA AND ANESTHESIA$327,000
R01 · FY2002 · GM
REGULATION OF NO SIGNALING IN PULMONARY VASCULATURE$366,146
R01 · FY2001 · HL
NO SIGNALING IN MECHANISMS OF ANALGESIA AND ANESTHESIA$327,083
R01 · FY2001 · GM
REGULATION OF NO SIGNALING IN PULMONARY VASCULATURE$360,078
R01 · FY2000 · HL
NO SIGNALING IN MECHANISMS OF ANALGESIA AND ANESTHESIA$353,000
R01 · FY2000 · GM